1Sagae S,Kudo R,Kuzumaki N,et al.Ras oncogene expression and progression in intraepithelial neoplasia of the uterine cervix[].Cancer.1990
2Sagae S,Kuzumaki N,Hisada T,et al.Ras oncogene expression and prognosis of invasive squamous cell carcinomas of the uterine cervix[].Cancer.1989
3Holm R,Skomedal H,Belland A,et al.Immunohistochemical analysis of p53 protein overexpression in normal, premalignant and malignant tissues of the cervix uteri[].Journal of Paleopathology.1993
4Bosari S,Roncalli M,Viale G,et al.p53 immunoreactivity in inflammatory and neoplastic diseases of the uterine cervix[].Journal of Paleopathology.1993
3Huh J J, Wolf[J] K, Fightmaster D L, et al. Transduction of adenovirus-mediated wild-type p53 after radiotherapy in human cervical cancer cells[J] Gynecol Oncol, 2003,89 (2):243-7.
4Khaled A, Imamura Y, Noriki S, et al. Early progression stage of malignancy of uterine cervical dysplasia as revealed by immunohistochemical demonstration of increased DNA-instability[J] . Eur[J] Histochem, 2000, 44(2):143-9.
5Chou R H, Huang H. Restoration of p53 tumor suppressor pathway in human cervical carcinoma cells by sodium arsenite[J] . Biochem Biophys Res Commun, 2002, 293(1):2981-4.
6Graflund M, Sorbe B, Karlsson M. MIB-1, p53, bcl-2, and WAF-1 expression in pelvic lymph nodes and primary tumors in early stage cervical carcinomas: correlation with clinical outcome[J]. Int J Oncol , 2002,20(5):1041-5.
7Costa S, Terzano P, Santini D, et al. Neoadjuvant chemotherapy in cervical carcinoma: regulators of cell cycle, apoptosis, and proliferation as determinants of response to therapy and disease outcome[J] . Am J Clin Pathol, 2001, 116(5):729-33.
8Clarke B, Chetty R. Cell cycle aberrations in the pathogenesis of squamous cell carcinoma of the uterine cervix[J]. Gynecol Oncol, 2001,82(2):238-41.
9Quade B J, Yang A, Wang Y, et al. Cviko A . Ex pression of the p53 homologue p63 in early cervical neoplasia[J]. Gynecol Oncol, 2001,80(1):2-7.
10Unger T, Nau M M, Segal S, et al. p53:a transdominant regulator of transcription whose function is ablated by mutations occurring in human cancer[J]. EMBO J ,1992,11(3):1383-8.
